MARKET

FBRX

FBRX

Forte Biosciences Inc
NASDAQ
76.92
+0.03
+0.04%
After Hours: 76.92 0 0.00% 19:49 08/21 EDT
OPEN
76.94
PREV CLOSE
76.89
HIGH
76.95
LOW
76.89
VOLUME
2.01M
TURNOVER
--
52 WEEK HIGH
77.20
52 WEEK LOW
10.11
MARKET CAP
1.63B
P/E (TTM)
-16.7101
1D
5D
1M
3M
1Y
5Y
1D
Forte Biosciences’ FB102 Trial Moves Forward: What Investors Should Watch
TipRanks · 4d ago
Weekly Report: what happened at FBRX last week (0810-0814)?
Weekly Report · 6d ago
Alger Small Cap Growth Fund Q2 2026 Portfolio Review
Seeking Alpha · 08/14 09:00
Execution Risks Threaten Forte Biosciences–argenx Merger and Shareholder Value
TipRanks · 08/14 06:01
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Forte Biosciences (FBRX) and Demant (OtherWILLF)
TipRanks · 08/13 07:20
Forte Biosciences Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Forte Biosciences, Inc. - FBRX
Barchart · 08/11 10:56
Weekly Report: what happened at FBRX last week (0803-0807)?
Weekly Report · 08/10 10:25
FBRX Stock Alert: Halper Sadeh LLC is Investigating Whether Forte Biosciences, Inc. is Obtaining a Fair Price for its Shareholders
Barchart · 08/08 08:54
More
About FBRX
Forte Biosciences, Inc. is a clinical-stage biopharmaceutical company that is advancing FB102, which is an anti-CD122 monoclonal antibody therapeutic candidate with potentially broad autoimmune and autoimmune-related indications. It is advancing clinical development of FB102 into patient-based trials for celiac disease and non-segmental vitiligo. The Company's FB102 program focuses on addressing key pathways implicated in these indications with a CD122 antagonist. CD122 is a subunit of IL-2/IL-15 receptors which are key regulators of NK cells and certain T cell subsets. FB102 has potentially other autoimmune and autoimmune-related applications including vitiligo, alopecia areata, and type 1 diabetes (T1D). Its subsidiaries include Forte Subsidiary, Inc. and Forte Biosciences Australia Proprietary Limited.

Webull offers Forte Biosciences Inc stock information, including NASDAQ: FBRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, FBRX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading FBRX stock methods without spending real money on the virtual paper trading platform.